Results of these two studies will be submitted to the U.S. Food and Drug Administration for consideration for approval of TMC278.TMC278 is the third anti-HIV compound to be developed by Tibotec Pharmaceuticals. Tibotec Pharmaceuticals developed other experimental compounds for the treatment of hepatitis C, and tuberculosis.About Tibotec Pharmaceuticals Ltd.Tibotec Pharmaceuticals Ltd., based in Cork, is a pharmaceutical research and development company. The company is focused on research and development facilities are in Mechelen, Belgium with offices in Yardley, Tibotec is dedicated to the discovery and development of innovative HIV / AIDS drugs and anti-infectives for diseases high unmet medical need dedicated. – Tibotec is a member of the Johnson & Johnson group of companies..
The first phase III, double – blind, randomized study, greater than 509 or ECHO announced evaluate TMC278 once-daily tablet compared with EFV once daily, when she composed with a fixed background regimen combination of emtricitabine+ tenofovir disoproxil fumarate.
Announced that two Phase III efficacy trials TMC278 test his experimental non-nucleoside reverse transcriptase inhibitor , are in treatment – naive adults with HIV-1 is now enrolling patients. The global studies compare the efficacy, safety and tolerability of TMC278 once-daily tablet of efavirenz , the[t] each coadministered with a background regimen of two nucleoside / nucleotide reverse transcriptase inhibitors adults, in treatment-experienced HIV-1-infected..Special program on Tuesday, July Shahab Sokhansanj of Oak Ridge National Laboratory led to new issues and technologies development of of bioenergy alternative products, including biomass and Parts are associated. Keynote Cindy Riley, National Renewable Energy Laboratory will a biofuels summary and strategic plan, at 9:30 clock takes The Biofuels Programme place in the ballroom of to the convention center. More special program plan to advances in ground and hydraulic engineering, having presentation in restore the ecosystem, low-cost irrigation system in developing countries, – level, threet diameter.
At the high school level, three national finalists in the ASABE100 will be a multi-media competition, to compete presentations of cash awards out of up to $ 4000 . That up on users across Germany, the answer to the question have been sought selected: ‘What will the biggest technical challenge of the next 50 years? ‘.
More than 1,100 technological presentations can be to topics that soil and water quality, use of pesticides technology, agricultural waste, wetlands in renewable energy, of food safety, and much view more plan include.